急性初级保健入院期间协作式药物审查对多重用药老年人的随机对照试验
本研究在挪威奥斯陆市政住院急性护理单元纳入137例≥70岁、使用≥6种常规药物的老年人,随机分组接受结构化协作药物审查或常规护理。16周时15D健康相关生活质量评分组间无显著差异(均差0.009;95%CI -0.063至0.079;结论认为急性入院期间协作药物审查未改善健康相关生活质量。
要点
- 急性入院期间协作药物审查未改善16周健康相关生活质量。
- 干预组住院期间药物调整更多,但出院后差异缩小。
- 躯体功能、认知功能、口腔健康、医疗利用及死亡率均无差异。
核心结论
- 在急性初级保健入院期间进行协作式药物审查未改善老年人的健康相关生活质量。
- 研究提示需在临床稳定阶段启动纵向、以患者为中心的策略。
研究设计与样本
- 单盲、平行组随机对照试验,在挪威奥斯陆市政住院急性护理单元进行。
- 纳入137例≥70岁、使用≥6种常规药物的患者,按1:1随机分为结构化药物审查组(67例)和常规护理组(70例)。
- 干预由接受全科医学专业培训的MIPAC医生评估、老年医学督导并与患者全科医生讨论。
主要发现
- 干预组住院期间药物调整更多,但出院后差异缩小。
- 次级结局包括躯体功能、认知功能、口腔健康、医疗利用及死亡率均无差异。
临床怎么用
- 急性入院期间不宜仅依靠协作药物审查来期望改善健康相关生活质量。
- 药物优化策略可考虑在临床稳定阶段以纵向、以患者为中心的方式实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Polypharmacy in older adults is associated with inappropriate prescribing and adverse drug events. In a previous trial, we demonstrated improved Health-Related Quality of Life (HRQoL) following medication reviews by geriatricians and general practitioners in home-dwelling older adults. Whether similar benefits can be achieved during acute admissions in primary care remains unclear. OBJECTIVE: To assess the effect of collaborative medication reviews during acute admissions to a Municipal Inpatient Acute Care (MIPAC) unit. METHODS: In this single-blind, parallel-group, randomised controlled trial, patients ≥70 years using ≥6 regular medications admitted to a MIPAC unit in Oslo, Norway, were randomised 1:1 to receive either a structured medication review or usual care. The intervention involved assessment by MIPAC physicians specialised in general practice, geriatric supervision and discussion with the patient's general practitioner. The primary outcome was HRQoL measured with the 15D instrument at 16 weeks. Secondary outcomes included physical and cognitive function, oral health, healthcare utilisation and mortality. RESULTS: We included 137 participants (mean age 85 years, 69% women; 67 intervention, 70 control). At 16 weeks, there was no significant difference in 15D scores between groups (mean difference 0.009; 95% CI, -0.063 to 0.079; P = .8). The intervention group had more medication changes during admission, but differences diminished post-discharge. No differences were observed in secondary outcomes. CONCLUSION: Collaborative medication reviews during acute primary care admissions did not improve HRQoL. The findings underscore the need for longitudinal, patient-centred strategies initiated in clinically stable phases.
引用
- Roa Santervas L, Skovlund E, Kristoffersen ES, et al. Collaborative medication reviews during acute primary care admissions for older adults with polypharmacy: a randomised controlled trial. Age Ageing. 2026. PMID: 41719423. doi:10.1093/ageing/afag029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。